Market Research Logo

Colombia Pharmaceuticals and Healthcare Report Q2 2016

Colombia Pharmaceuticals and Healthcare Report Q2 2016

BMI View: A growing burden of chronic diseases, along with the Colombian government's push toward improving health coverage, will ensure the country's retained appeal to multinational drugmakers and healthcare suppliers. However, inefficiencies and debt within healthcare provision will fuel instability in the healthcare sector.

Headline Expenditure Projections

Pharmaceuticals: COP9,101bn (USD3.31bn) in 2015 to COP9,584bn (USD2.92bn) in 2016; +5.3% in local currency and -12.0% in US dollars.

Healthcare: COP54,299bn (USD19.8bn) in 2015 to COP57,940bn (USD17.6bn) in 2016; +6.7% in local currency and -10.9% in US dollars.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Colombia 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Colombia 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Colombia 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Colombia 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Colombia 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Colombia 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Colombia 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Colombia 2014-2020)
Pharmaceuticals Risk/Reward Index
Americas Risk/Reward Index
Colombia Risk/Reward Index
Rewards
Risks
Market Overview
Healthcare Sector
Table: Healthcare Resources (Colombia 2010-2015)
Table: Healthcare Personnel (Colombia 2010-2015)
Table: Healthcare Activity (Colombia 2010-2015)
Research & Development
Table: Pharmaceutical Research and Science Centre (CECIF) Members, 2015
Clinical Trials
Epidemiology
Regulatory Review
Intellectual Property Regime
Table: Colombia-US FTA Mechanisms Relevant To Intellectual Property
Pricing Regime
Reimbursement Regime
Competitive Landscape
Research-Based Industry
Table: Members Of Asociación De Laboratorios Farmacéuticos De Investigación (AFIDRO), 2012
Table: Multinational Market Activity
Table: Leading Pharmaceutical Companies By Revenues, 2011 (COPmn)
Pharmaceutical Distribution
Table: Leading Pharmaceutical Importers/Wholesalers By Revenues, 2011
Pharmaceutical Retail Sector
Company Profile
Laboratorios Bussié
Laboratorios Genfar SA
Lafrancol
Demographic Forecast
Table: Population Headline Indicators (Colombia 1990-2025)
Table: Key Population Ratios (Colombia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Colombia 1990-2025)
Table: Population By Age Group (Colombia 1990-2025)
Table: Population By Age Group % (Colombia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report